ID   RAD18_HUMAN             Reviewed;         495 AA.
AC   Q9NS91; Q58F55; Q9NRT6;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   18-JUN-2025, entry version 205.
DE   RecName: Full=E3 ubiquitin-protein ligase RAD18;
DE            EC=2.3.2.27;
DE   AltName: Full=Postreplication repair protein RAD18;
DE            Short=hHR18;
DE            Short=hRAD18;
DE   AltName: Full=RING finger protein 73;
DE   AltName: Full=RING-type E3 ubiquitin transferase RAD18 {ECO:0000305};
GN   Name=RAD18; Synonyms=RNF73;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-302.
RC   TISSUE=Placenta;
RX   PubMed=10884424; DOI=10.1073/pnas.97.14.7927;
RA   Tateishi S., Sakuraba Y., Masuyama S., Inoue H., Yamaizumi M.;
RT   "Dysfunction of human Rad18 results in defective postreplication repair and
RT   hypersensitivity to multiple mutagens.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:7927-7932(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-302.
RX   PubMed=10908344; DOI=10.1093/nar/28.14.2847;
RA   Xin H., Lin W., Sumanasekera W., Zhang Y., Wu X., Wang Z.;
RT   "The human RAD18 gene product interacts with HHR6A and HHR6B.";
RL   Nucleic Acids Res. 28:2847-2854(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-302.
RA   Jang Y., Chae S.;
RT   "Identification of human RAD18 (hHR18), a homolog of yeast RAD18.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-302.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-6; GLN-302 AND VAL-307.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-302.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH SLF1, AND SUBCELLULAR LOCATION.
RX   PubMed=15632077; DOI=10.1128/mcb.25.2.779-788.2005;
RA   Adams D.J., van der Weyden L., Gergely F.V., Arends M.J., Ng B.L.,
RA   Tannahill D., Kanaar R., Markus A., Morris B.J., Bradley A.;
RT   "BRCTx is a novel, highly conserved RAD18-interacting protein.";
RL   Mol. Cell. Biol. 25:779-788(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   INTERACTION WITH SHPRH.
RX   PubMed=17130289; DOI=10.1083/jcb.200606145;
RA   Motegi A., Sood R., Moinova H., Markowitz S.D., Liu P.P., Myung K.;
RT   "Human SHPRH suppresses genomic instability through proliferating cell
RT   nuclear antigen polyubiquitination.";
RL   J. Cell Biol. 175:703-708(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH SHPRH.
RX   PubMed=17108083; DOI=10.1073/pnas.0608595103;
RA   Unk I., Hajdu I., Fatyol K., Szakal B., Blastyak A., Bermudez V.,
RA   Hurwitz J., Prakash L., Prakash S., Haracska L.;
RT   "Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent
RT   polyubiquitylation of proliferating cell nuclear antigen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:18107-18112(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; THR-118 AND
RP   SER-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   INTERACTION WITH HLTF.
RX   PubMed=18316726; DOI=10.1073/pnas.0800563105;
RA   Unk I., Hajdu I., Fatyol K., Hurwitz J., Yoon J.-H., Prakash L.,
RA   Prakash S., Haracska L.;
RT   "Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear
RT   antigen polyubiquitination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3768-3773(2008).
RN   [16]
RP   INTERACTION WITH HLTF.
RX   PubMed=18719106; DOI=10.1073/pnas.0805685105;
RA   Motegi A., Liaw H.-J., Lee K.-Y., Roest H.P., Maas A., Wu X., Moinova H.,
RA   Markowitz S.D., Ding H., Hoeijmakers J.H.J., Myung K.;
RT   "Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH
RT   prevents genomic instability from stalled replication forks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12411-12416(2008).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-103, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-471, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-471, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   FUNCTION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=21659603; DOI=10.1126/science.1203430;
RA   Cotta-Ramusino C., McDonald E.R. III, Hurov K., Sowa M.E., Harper J.W.,
RA   Elledge S.J.;
RT   "A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1
RT   interacting protein required for ATR signaling.";
RL   Science 332:1313-1317(2011).
RN   [22]
RP   INTERACTION WITH SLF1, SUBCELLULAR LOCATION, AND MUTAGENESIS OF SER-442 AND
RP   SER-444.
RX   PubMed=22036607; DOI=10.1016/j.dnarep.2011.10.012;
RA   Liu T., Chen H., Kim H., Huen M.S., Chen J., Huang J.;
RT   "RAD18-BRCTx interaction is required for efficient repair of UV-induced DNA
RT   damage.";
RL   DNA Repair 11:131-138(2012).
RN   [23]
RP   UBIQUITIN-BINDING, AND LR MOTIF.
RX   PubMed=22742833; DOI=10.1016/j.molcel.2012.05.045;
RA   Panier S., Ichijima Y., Fradet-Turcotte A., Leung C.C., Kaustov L.,
RA   Arrowsmith C.H., Durocher D.;
RT   "Tandem protein interaction modules organize the ubiquitin-dependent
RT   response to DNA double-strand breaks.";
RL   Mol. Cell 47:383-395(2012).
RN   [24]
RP   INTERACTION WITH SPRTN.
RX   PubMed=22681887; DOI=10.1016/j.molcel.2012.05.020;
RA   Centore R.C., Yazinski S.A., Tse A., Zou L.;
RT   "Spartan/C1orf124, a reader of PCNA ubiquitylation and a regulator of UV-
RT   induced DNA damage response.";
RL   Mol. Cell 46:625-635(2012).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99; SER-103; THR-118;
RP   SER-122; SER-125; SER-142; SER-158; SER-164; SER-322; SER-471 AND SER-483,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-376, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [28]
RP   INTERACTION WITH SLF1; SLF2 AND SMC5, SUBCELLULAR LOCATION, IDENTIFICATION
RP   BY MASS SPECTROMETRY, AND MUTAGENESIS OF SER-442 AND SER-444.
RX   PubMed=25931565; DOI=10.1126/science.1253671;
RA   Raeschle M., Smeenk G., Hansen R.K., Temu T., Oka Y., Hein M.Y.,
RA   Nagaraj N., Long D.T., Walter J.C., Hofmann K., Storchova Z., Cox J.,
RA   Bekker-Jensen S., Mailand N., Mann M.;
RT   "DNA repair. Proteomics reveals dynamic assembly of repair complexes during
RT   bypass of DNA cross-links.";
RL   Science 348:1253671-1253671(2015).
RN   [29]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-376, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [30]
RP   INTERACTION WITH DDUP AND H2AX.
RX   PubMed=35849344; DOI=10.1093/nar/gkac611;
RA   Yu R., Hu Y., Zhang S., Li X., Tang M., Yang M., Wu X., Li Z., Liao X.,
RA   Xu Y., Li M., Chen S., Qian W., Gong L.Y., Song L., Li J.;
RT   "LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response
RT   signalling to trigger dual DNA repair mechanisms.";
RL   Nucleic Acids Res. 50:8060-8079(2022).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-99, SUBUNIT, AND MUTAGENESIS OF
RP   ILE-27.
RX   PubMed=21549715; DOI=10.1016/j.jmb.2011.04.051;
RA   Huang A., Hibbert R.G., de Jong R.N., Das D., Sixma T.K., Boelens R.;
RT   "Symmetry and asymmetry of the RING-RING dimer of Rad18.";
RL   J. Mol. Biol. 410:424-435(2011).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase involved in postreplication
CC       repair of UV-damaged DNA. Postreplication repair functions in gap-
CC       filling of a daughter strand on replication of damaged DNA. Associates
CC       to the E2 ubiquitin conjugating enzyme UBE2B to form the UBE2B-RAD18
CC       ubiquitin ligase complex involved in mono-ubiquitination of DNA-
CC       associated PCNA on 'Lys-164'. Has ssDNA binding activity.
CC       {ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:21659603}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homodimer (PubMed:21549715). Interacts with UBE2A and UBE2B,
CC       one homodimer binding one molecule of UBE2B. Interacts with SHPRH
CC       (PubMed:17108083, PubMed:17130289). Interacts with HLTF
CC       (PubMed:18316726, PubMed:18719106). Interacts with SPRTN; leading to
CC       enhance chromatin association of RAD18 and RAD18-mediated PCNA
CC       ubiquitination and translesion DNA synthesis (PubMed:22681887).
CC       Interacts (via C-terminus and phosphorylated form) with SLF1 (via BRCT
CC       domains); this interaction is required for efficient repair of UV-
CC       induced DNA damage (PubMed:15632077, PubMed:22036607, PubMed:25931565).
CC       Interacts with SLF2 (PubMed:25931565). Interacts with SMC5; this
CC       interaction is increased in a SLF1 or SLF2-dependent manner
CC       (PubMed:25931565). Interacts with DNA damage up-regulated protein DDUP
CC       (PubMed:35849344). Forms a complex with DDUP and H2AX following DDUP
CC       phosphorylation (PubMed:35849344). {ECO:0000269|PubMed:15632077,
CC       ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289,
CC       ECO:0000269|PubMed:18316726, ECO:0000269|PubMed:18719106,
CC       ECO:0000269|PubMed:21549715, ECO:0000269|PubMed:22036607,
CC       ECO:0000269|PubMed:22681887, ECO:0000269|PubMed:25931565,
CC       ECO:0000269|PubMed:35849344}.
CC   -!- INTERACTION:
CC       Q9NS91; Q96B67: ARRDC3; NbExp=3; IntAct=EBI-2339393, EBI-2875665;
CC       Q9NS91; P54253: ATXN1; NbExp=6; IntAct=EBI-2339393, EBI-930964;
CC       Q9NS91; Q15038: DAZAP2; NbExp=3; IntAct=EBI-2339393, EBI-724310;
CC       Q9NS91; Q08379: GOLGA2; NbExp=3; IntAct=EBI-2339393, EBI-618309;
CC       Q9NS91; Q14527: HLTF; NbExp=3; IntAct=EBI-2339393, EBI-1045161;
CC       Q9NS91; P43358: MAGEA4; NbExp=6; IntAct=EBI-2339393, EBI-743122;
CC       Q9NS91; Q13416: ORC2; NbExp=3; IntAct=EBI-2339393, EBI-374957;
CC       Q9NS91; O14737: PDCD5; NbExp=3; IntAct=EBI-2339393, EBI-712290;
CC       Q9NS91; Q13148: TARDBP; NbExp=3; IntAct=EBI-2339393, EBI-372899;
CC       Q9NS91; Q86VP1: TAX1BP1; NbExp=6; IntAct=EBI-2339393, EBI-529518;
CC       Q9NS91; P49459: UBE2A; NbExp=4; IntAct=EBI-2339393, EBI-2339348;
CC       Q9NS91; P63146: UBE2B; NbExp=7; IntAct=EBI-2339393, EBI-712629;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15632077,
CC       ECO:0000269|PubMed:22036607, ECO:0000269|PubMed:25931565}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:15632077}. Note=Associates with chromatin
CC       (PubMed:25931565). Colocalizes with SLF1 in the nucleus and to
CC       centrosomes (PubMed:15632077). Relocalizes with SLF1 to nuclear foci in
CC       response to DNA damage (PubMed:22036607). Accumulates with the SLF1-
CC       SLF2 and SMC5-SMC6 complexes at replication-coupled DNA interstrand
CC       repair and DNA double-strand breaks (DSBs) sites on chromatin in a
CC       ubiquitin-dependent manner (PubMed:25931565).
CC       {ECO:0000269|PubMed:15632077, ECO:0000269|PubMed:22036607,
CC       ECO:0000269|PubMed:25931565}.
CC   -!- SIMILARITY: Belongs to the RAD18 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB035274; BAA99284.1; -; mRNA.
DR   EMBL; AF169796; AAF80856.1; -; mRNA.
DR   EMBL; AY004333; AAF86618.1; -; mRNA.
DR   EMBL; AK023075; BAB14392.1; -; mRNA.
DR   EMBL; AY961989; AAX44049.1; -; Genomic_DNA.
DR   EMBL; AC008151; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC034186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001302; AAH01302.1; -; mRNA.
DR   CCDS; CCDS2571.1; -.
DR   RefSeq; NP_064550.3; NM_020165.3.
DR   PDB; 2MRE; NMR; -; B=198-227.
DR   PDB; 2MRF; NMR; -; A=198-227.
DR   PDB; 2Y43; X-ray; 1.80 A; A/B=1-99.
DR   PDB; 2YBF; X-ray; 2.00 A; B=340-366.
DR   PDB; 5VF0; NMR; -; B=198-240.
DR   PDB; 8IR2; X-ray; 1.75 A; C/D=436-452.
DR   PDB; 8IR4; X-ray; 1.62 A; C/D=436-452.
DR   PDB; 9BD3; X-ray; 2.58 A; B/D=339-366.
DR   PDBsum; 2MRE; -.
DR   PDBsum; 2MRF; -.
DR   PDBsum; 2Y43; -.
DR   PDBsum; 2YBF; -.
DR   PDBsum; 5VF0; -.
DR   PDBsum; 8IR2; -.
DR   PDBsum; 8IR4; -.
DR   PDBsum; 9BD3; -.
DR   AlphaFoldDB; Q9NS91; -.
DR   SMR; Q9NS91; -.
DR   BioGRID; 121212; 468.
DR   CORUM; Q9NS91; -.
DR   DIP; DIP-29831N; -.
DR   FunCoup; Q9NS91; 1816.
DR   IntAct; Q9NS91; 88.
DR   MINT; Q9NS91; -.
DR   STRING; 9606.ENSP00000264926; -.
DR   GlyGen; Q9NS91; 5 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (3 sites).
DR   iPTMnet; Q9NS91; -.
DR   MetOSite; Q9NS91; -.
DR   PhosphoSitePlus; Q9NS91; -.
DR   SwissPalm; Q9NS91; -.
DR   BioMuta; RAD18; -.
DR   DMDM; 313104165; -.
DR   CPTAC; CPTAC-3246; -.
DR   CPTAC; CPTAC-3247; -.
DR   CPTAC; CPTAC-3285; -.
DR   CPTAC; CPTAC-939; -.
DR   CPTAC; CPTAC-940; -.
DR   jPOST; Q9NS91; -.
DR   MassIVE; Q9NS91; -.
DR   PaxDb; 9606-ENSP00000264926; -.
DR   PeptideAtlas; Q9NS91; -.
DR   ProteomicsDB; 82515; -.
DR   Pumba; Q9NS91; -.
DR   Antibodypedia; 10148; 426 antibodies from 40 providers.
DR   CPTC; Q9NS91; 5 antibodies.
DR   DNASU; 56852; -.
DR   Ensembl; ENST00000264926.7; ENSP00000264926.2; ENSG00000070950.10.
DR   GeneID; 56852; -.
DR   KEGG; hsa:56852; -.
DR   MANE-Select; ENST00000264926.7; ENSP00000264926.2; NM_020165.4; NP_064550.3.
DR   UCSC; uc003brd.4; human.
DR   AGR; HGNC:18278; -.
DR   CTD; 56852; -.
DR   DisGeNET; 56852; -.
DR   GeneCards; RAD18; -.
DR   HGNC; HGNC:18278; RAD18.
DR   HPA; ENSG00000070950; Low tissue specificity.
DR   MIM; 605256; gene.
DR   OpenTargets; ENSG00000070950; -.
DR   VEuPathDB; HostDB:ENSG00000070950; -.
DR   eggNOG; KOG0287; Eukaryota.
DR   GeneTree; ENSGT00390000011230; -.
DR   InParanoid; Q9NS91; -.
DR   OMA; IPNTGPR; -.
DR   OrthoDB; 9049620at2759; -.
DR   PAN-GO; Q9NS91; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NS91; -.
DR   PathwayCommons; Q9NS91; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SignaLink; Q9NS91; -.
DR   SIGNOR; Q9NS91; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 56852; 52 hits in 1199 CRISPR screens.
DR   ChiTaRS; RAD18; human.
DR   EvolutionaryTrace; Q9NS91; -.
DR   GeneWiki; RAD18; -.
DR   GenomeRNAi; 56852; -.
DR   Pharos; Q9NS91; Tbio.
DR   PRO; PR:Q9NS91; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NS91; protein.
DR   Bgee; ENSG00000070950; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 145 other cell types or tissues.
DR   ExpressionAtlas; Q9NS91; baseline and differential.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0042405; C:nuclear inclusion body; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0097505; C:Rad6-Rad18 complex; IBA:GO_Central.
DR   GO; GO:0005657; C:replication fork; IDA:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; NAS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IDA:MGI.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; IEA:InterPro.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:InterPro.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0000403; F:Y-form DNA binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:DNA damage response; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; NAS:UniProtKB.
DR   GO; GO:0051984; P:positive regulation of chromosome segregation; IMP:UniProtKB.
DR   GO; GO:0006301; P:postreplication repair; IBA:GO_Central.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:MGI.
DR   GO; GO:0006513; P:protein monoubiquitination; IBA:GO_Central.
DR   CDD; cd16529; RING-HC_RAD18; 1.
DR   FunFam; 3.30.160.60:FF:000331; E3 ubiquitin-protein ligase RAD18; 1.
DR   FunFam; 3.30.40.10:FF:000172; E3 ubiquitin-protein ligase RAD18; 1.
DR   FunFam; 1.10.720.30:FF:000024; E3 ubiquitin-protein ligase RAD18 isoform X1; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 1.10.720.30; SAP domain; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   IDEAL; IID00588; -.
DR   InterPro; IPR039577; Rad18.
DR   InterPro; IPR006642; Rad18_UBZ4.
DR   InterPro; IPR003034; SAP_dom.
DR   InterPro; IPR036361; SAP_dom_sf.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR14134; E3 UBIQUITIN-PROTEIN LIGASE RAD18; 1.
DR   PANTHER; PTHR14134:SF2; E3 UBIQUITIN-PROTEIN LIGASE RAD18; 1.
DR   Pfam; PF02037; SAP; 1.
DR   Pfam; PF13923; zf-C3HC4_2; 1.
DR   SMART; SM00184; RING; 1.
DR   SMART; SM00513; SAP; 1.
DR   SMART; SM00734; ZnF_Rad18; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50800; SAP; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
DR   PROSITE; PS51908; ZF_UBZ4; 1.
DR   neXtProt; NX_Q9NS91; -.
DR   PharmGKB; PA134912253; -.
DR   TreeFam; TF101214; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Cytoskeleton; DNA damage; DNA repair;
KW   DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..495
FT                   /note="E3 ubiquitin-protein ligase RAD18"
FT                   /id="PRO_0000056149"
FT   DOMAIN          248..282
FT                   /note="SAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00186"
FT   ZN_FING         25..64
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         201..228
FT                   /note="UBZ4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   REGION          152..197
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          400..423
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          456..495
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           232..240
FT                   /note="LR motif"
FT   COMPBIAS        410..421
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        479..495
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         204
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         207
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         219
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         223
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         99
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18220336, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         118
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         125
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         471
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16964243,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        376
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   VARIANT         6
FT                   /note="E -> A (in dbSNP:rs45520133)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_023423"
FT   VARIANT         302
FT                   /note="R -> Q (in dbSNP:rs373572)"
FT                   /evidence="ECO:0000269|PubMed:10884424,
FT                   ECO:0000269|PubMed:10908344, ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.3,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_023424"
FT   VARIANT         307
FT                   /note="I -> V (in dbSNP:rs45569933)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_023425"
FT   MUTAGEN         27
FT                   /note="I->A: Lower activity toward PCNA
FT                   monoubiquitination."
FT                   /evidence="ECO:0000269|PubMed:21549715"
FT   MUTAGEN         442
FT                   /note="S->A: Does not interact with SLF1 and is defective
FT                   in restoring cell survival after DNA damage; when
FT                   associated with A-444."
FT                   /evidence="ECO:0000269|PubMed:22036607,
FT                   ECO:0000269|PubMed:25931565"
FT   MUTAGEN         444
FT                   /note="S->A: Does not interact with SLF1 and is defective
FT                   in restoring cell survival after DNA damage; when
FT                   associated with A-442."
FT                   /evidence="ECO:0000269|PubMed:22036607,
FT                   ECO:0000269|PubMed:25931565"
FT   CONFLICT        191
FT                   /note="P -> L (in Ref. 2; AAF80856)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        482..484
FT                   /note="ESA -> GKC (in Ref. 2; AAF80856)"
FT                   /evidence="ECO:0000305"
FT   HELIX           11..16
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   HELIX           17..22
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   TURN            26..28
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   STRAND          33..37
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   TURN            39..41
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   STRAND          44..46
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   HELIX           47..54
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   TURN            61..63
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   HELIX           69..71
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   HELIX           76..90
FT                   /evidence="ECO:0007829|PDB:2Y43"
FT   STRAND          201..204
FT                   /evidence="ECO:0007829|PDB:2MRE"
FT   TURN            205..208
FT                   /evidence="ECO:0007829|PDB:2MRE"
FT   STRAND          209..212
FT                   /evidence="ECO:0007829|PDB:2MRE"
FT   HELIX           213..223
FT                   /evidence="ECO:0007829|PDB:2MRE"
FT   STRAND          236..238
FT                   /evidence="ECO:0007829|PDB:5VF0"
FT   HELIX           342..345
FT                   /evidence="ECO:0007829|PDB:2YBF"
FT   HELIX           347..358
FT                   /evidence="ECO:0007829|PDB:2YBF"
FT   HELIX           438..440
FT                   /evidence="ECO:0007829|PDB:8IR4"
FT   HELIX           446..451
FT                   /evidence="ECO:0007829|PDB:8IR4"
SQ   SEQUENCE   495 AA;  56223 MW;  744A053A50C65DD7 CRC64;
     MDSLAESRWP PGLAVMKTID DLLRCGICFE YFNIAMIIPQ CSHNYCSLCI RKFLSYKTQC
     PTCCVTVTEP DLKNNRILDE LVKSLNFARN HLLQFALESP AKSPASSSSK NLAVKVYTPV
     ASRQSLKQGS RLMDNFLIRE MSGSTSELLI KENKSKFSPQ KEASPAAKTK ETRSVEEIAP
     DPSEAKRPEP PSTSTLKQVT KVDCPVCGVN IPESHINKHL DSCLSREEKK ESLRSSVHKR
     KPLPKTVYNL LSDRDLKKKL KEHGLSIQGN KQQLIKRHQE FVHMYNAQCD ALHPKSAAEI
     VREIENIEKT RMRLEASKLN ESVMVFTKDQ TEKEIDEIHS KYRKKHKSEF QLLVDQARKG
     YKKIAGMSQK TVTITKEDES TEKLSSVCMG QEDNMTSVTN HFSQSKLDSP EELEPDREED
     SSSCIDIQEV LSSSESDSCN SSSSDIIRDL LEEEEAWEAS HKNDLQDTEI SPRQNRRTRA
     AESAEIEPRN KRNRN
//
